Form 13D/A STAAR SURGICAL CO For: 16 January
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
STAAR Surgical Company (STAA)
STAAR Surgical Company stock price live, this page displays NASDAQ STAA stock exchange data. View the STAA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the STAAR Surgical Company real time stock price chart below.
What Is the STAAR Surgical Company Stock Price Today?
The STAAR Surgical Company stock price today is 18.04.
What Is the Stock Symbol for STAAR Surgical Company?
The stock symbol for STAAR Surgical Company is "STAA."
What Stock Exchange Does STAAR Surgical Company Trade On?
STAAR Surgical Company is listed and trades on the NASDAQ stock exchange.
Is STAAR Surgical Company a Good Stock to Buy?
Determining whether STAAR Surgical Company—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the STAA quote. (ISIN: US8523123052)
What Is the STAAR Surgical Company Stock Price Today?
The STAAR Surgical Company stock price today is 18.04.
What Is the Stock Symbol for STAAR Surgical Company?
The stock symbol for STAAR Surgical Company is "STAA."
What Stock Exchange Does STAAR Surgical Company Trade On?
STAAR Surgical Company is listed and trades on the NASDAQ stock exchange.
Is STAAR Surgical Company a Good Stock to Buy?
Determining whether STAAR Surgical Company—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the STAA quote. (ISIN: US8523123052)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.00
19.00
52 wk Range
13.50
30.81
STAA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.0019.00
52 wk Range
13.5030.81
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
STAA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
23.36
Upside
+29.50%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
- Form 8K STAAR Surgical Company For: 16 January
- Investing.com
- Form 13D/A STAAR SURGICAL CO For: 16 January
- Investing.com
- Form 8K STAAR Surgical Company For: 16 January
- Investing.com
- STAAR Surgical receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
STAAR Surgical Company Company Profile
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
STAAR Surgical Company Earnings Call Summary for Q1/2025
- Q1 2025 EPS at -$1.10, missing -$0.58 forecast; revenue beat at $42.6M vs $40.33M expected; stock down 5.25% after-hours
- Total net sales dropped to $42.6M from $77.4M YoY; China sales plummeted to $389K from $38.5M; 9% growth excluding China
- New product EVO Plus (V5) lens launch planned for mid-2025 in China; company targets profitability in H2 2025
- Previous financial guidance withdrawn; aiming for 70% gross margin in H2 2025, long-term goal of 75-80%
- CEO emphasizes market potential and transparency; company faces challenges from China sales decline and new competitors
Last Updated: 2025-05-07, 06:48 p/m
Read Full TranscriptCompare STAA to Peers and Sector
Metrics to compare | STAA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSTAAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.3x | 11.3x | −0.6x | |
PEG Ratio | 0.02 | −0.06 | 0.00 | |
Price/Book | 2.5x | 2.9x | 2.6x | |
Price / LTM Sales | 3.9x | 3.4x | 3.4x | |
Upside (Analyst Target) | 21.4% | 38.8% | 44.9% | |
Fair Value Upside | Unlock | 9.7% | 6.3% | Unlock |
Analyst Ratings
1 Buy
9 Hold
1 Sell
Ratings:
11 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 23.36
(+29.50% Upside)
Earnings
Latest Release
Nov 05, 2025
EPS / Forecast
0.18 / 0.18
Revenue / Forecast
94.70M / 92.64M
People Also Watch
FAQ
What Is the STAAR Surgical (STAA) Stock Price Today?
The STAAR Surgical stock price today is 18.04
What Stock Exchange Does STAAR Surgical Trade On?
STAAR Surgical is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for STAAR Surgical?
The stock symbol for STAAR Surgical is "STAA."
What Is the STAAR Surgical Market Cap?
As of today, STAAR Surgical market cap is 897.34M.
What Is STAAR Surgical's Earnings Per Share (TTM)?
The STAAR Surgical EPS (TTM) is -1.95.
When Is the Next STAAR Surgical Earnings Date?
STAAR Surgical will release its next earnings report on Feb 25, 2026.
From a Technical Analysis Perspective, Is STAA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has STAAR Surgical Stock Split?
STAAR Surgical has split 1 times.
How Many Employees Does STAAR Surgical Have?
STAAR Surgical has 1157 employees.
What is the current trading status of STAAR Surgical (STAA)?
As of Feb 03, 2026, STAAR Surgical (STAA) is trading at a price of 18.04, with a previous close of 18.04. The stock has fluctuated within a day range of 18.00 to 19.00, while its 52-week range spans from 13.50 to 30.81.
What Is STAAR Surgical (STAA) Price Target According to Analysts?
The average 12-month price target for STAAR Surgical is USD23.36, with a high estimate of USD30.75 and a low estimate of USD13. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +29.50% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.